| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7e943fdb61fb0ae6ce0c544d4a668a2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-82 |
| filingDate |
2020-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdc8741c9565896ac81584a456c56d99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f0d950777f7c5f02a1a892776c6c78c |
| publicationDate |
2022-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-4025300-A1 |
| titleOfInvention |
Atp-regulated potassium channel openers comprising guanidine and uses thereof |
| abstract |
The present invention provides compounds comprising an ATP-regulated potassium (KATP) channel opener, and pharmaceutical compositions thereof. These compounds and compositions are useful for prevention, treatment, or management of pulmonary arterial or venous hypertension. |
| priorityDate |
2019-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |